Augmentation of Cocaine-Sensitized Dopamine Release in the Nucleus Accumbens of Adult Mice following Prenatal Cocaine Exposure

Developmental Neuroscience

Volumn 31, Issue 1-2, 2009, Pages 76-89

  Malanga, C J ^a,b   Ren, Jia Qian ^a   Guerriero, Réjean M ^a   Kosofsky, Barry E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine exposure, in utero; Drug abuse; Gestation; Microdialysis, in vivo; Sensitization; Withdrawal

Indexed keywords

COCAINE; DOPAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SENSITIZATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HYDROXYINDOLEACETIC ACID; MICE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN;

EID: 65349098865     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207496     Document Type: Article

References (110)

1. Ackerman JM, White FJ (1990): A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett 117: 181-187.
2. Akbari HM, Azmitia EC (1992): Increased tyrosine hydroxylase immunoreactivity in the rat cortex following prenatal cocaine exposure. Dev Brain Res 66: 277-281.
3. Alati R, Al Mamun A, Williams GM, O'Callaghan M, Najman JM, Bor W (2006): In utero alcohol exposure and prediction of alcohol disorders in early adulthood: a birth cohort study. Arch Gen Psychiatry 63: 1009-1016.
4. Al Mamun A, O'Callaghan FV, Alati R, O'Callaghan M, Najman JM, Williams GM, Bor W (2006): Does maternal smoking during pregnancy predict the smoking patterns of young adult offspring? A birth cohort study. Tob Control 15: 452-457.
5. Arbuthnott GW, Fairbrother IS, Butcher SP (1990): Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. Pharmacol Ther 48: 281-293.
6. Baer JS, Sampson PD, Barr HM, Connor PD, Streissguth AP (2003): A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch Gen Psychiatry 60: 377-385.
7. Bandstra ES, Morrow CE, Vogel AL, Fifer RC, Ofir AY, Dausa AT, Xue L, Anthony JC (2002): Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol 24: 297-308.
8. Bardo MT, Bevins RA (2000): Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153: 31-43.
9. Beitner-Johnson D, Nestler EJ (1991): Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57: 344-347.
10. Benloucif S, Galloway MP (1991): Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200: 1-8.
11. Benson KA, Ali SF, Wilson MC (1996): The effects of prenatal cocaine exposure on dopaminergic challenge and receptor binding in Wistar rats. Ann NY Acad Sci 801: 289-300.
12. Berridge KC, Robinson TE (1998): What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
13. Bonci A, Williams JT (1996): A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16: 631-639.
14. Byrnes JJ, Pritchard GA, Koff JM, Miller LG (1993): Prenatal cocaine exposure: decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring. Neuropharmacology 32: 721-723.
15. Cameron DL, Williams JT (1995): Opposing roles for dopamine and serotonin at presynaptic receptors in the ventral tegmental area. Clin Exp Pharmacol Physiol 22: 841-845.
16. Camp DM, Robinson TE (1992): On the use of multiple probe insertions at the same site for repeated intracerebral microdialysis experiments in the nigrostriatal dopamine system of rats. J Neurochem 58: 1706-1715.
17. Carelli RM (2004): Nucleus accumbens cell firing and rapid dopamine signaling during goal-directed behaviors in rats. Neuropharmacology 47(suppl 1):180-189.
18. Carlezon WA Jr, Duman RS, Nestler EJ (2005): The many faces of CREB. Trends Neurosci 28: 436-445.
19. Chasnoff IJ, Griffith DR, Freier C, Murray J (1992): Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics 89: 284-289.
20. Chefer VI, Shippenberg TS (2002): Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience 112: 907-919.
21. Chiriboga CA, Brust JC, Bateman D, Hauser WA (1999): Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 103: 79-85.
22. Clapp-Lilly KL, Roberts RC, Duffy LK, Irons KP, Hu Y, Drew KL (1999): An ultrastructural analysis of tissue surrounding a microdialysis probe. J Neurosci Methods 90: 129-142.
23. Cornelius MD, Leech SL, Goldschmidt L, Day NL (2000): Prenatal tobacco exposure: is it a risk factor for early tobacco experimentation? Nicotine Tob Res 2: 45-52.
24. Crozatier C, Guerriero RM, Mathieu F, Giros B, Nosten-Bertrand M, Kosofsky BE (2003): Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Res Dev Brain Res 147: 97-105.
25. Dahlström A, Fuxe K (1964): Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62(suppl 232):1-55.
26. de Lange EC, Danhof M, Zurcher C, de Boer AG, Breimer DD (1995): Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability. Brain Res 702: 261-265.
27. Fang Y, Ronnekleiv OK (1999): Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain. J Neurosci 19: 8966-8978.
28. Frank DA, Jacobs RR, Beeghly M, Augustyn M, Bellinger D, Cabral H, Heeren T (2002): Level of prenatal cocaine exposure and scores on the Bayley scales of infant development: modifying effects of caregiver, early intervention, and birth weight. Pediatrics 110: 1143-1152.
29. Friedman E, Yadin E, Wang HY (1996): Effect of prenatal cocaine on dopamine receptor-G Protein coupling in mesocortical regions of the rabbit brain. Neuroscience 70: 739-747.
30. Fumero B, Guadalupe T, Valladares F, Mora F, O'Neill RD, Mas M, Gonzalez-Mora JL (1994): Fixed versus removable microdialysis probes for in vivo neurochemical analysis: implications for behavioral studies. J Neurochem 63: 1407-1415.
31. Ghee M, Baker H, Miller JC, Ziff EB (1998): Ap-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene. Brain Res Mol Brain Res 55: 101-114.
32. Glatt SJ, Trksak GH, Cohen OS, Simeone BP, Jackson D (2004): Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex. Synapse 53: 74-89.
33. Griffith DR, Azuma SC, Chasnoff IJ (1994): Three-year outcome of children exposed prenatally to drugs. J Am Acad Child Psychiatry 33: 20-27.
34. Guerriero RM, Rajadhyaksha A, Crozatier C, Giros B, Nosten-Bertrand M, Kosofsky BE (2005): Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci 27: 235-248.
35. Heidbreder CA, Thompson AC, Shippenberg TS (1996): Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 278: 490-502.
36. Henry DJ, Greene MA, White FJ (1989): Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 251: 833-839.
37. Henry DJ, White FJ (1991): Repeated cocaine administration causes persistent enhancement of D 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258: 882-890.
38. Henry DJ, White FJ (1995): The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15: 6287-6299.
39. Heyser CJ, Miller JS, Spear NE, Spear LP (1992): Prenatal exposure to cocaine disrupts cocaine-induced conditioned place preference in rats. Neurotoxicol Teratol 14: 57-64.
40. Heyser CJ, Rajachandran L, Spear NE, Spear LP (1994): Responsiveness to cocaine challenge in adult rats following prenatal exposure to cocaine. Psychopharmacology (Berl) 116: 45-55.
41. Holson RR, Pearce B (1992): Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 14: 221-228.
42. Hutchings DE, Fico TA, Dow-Edwards DL (1989): Prenatal cocaine: maternal toxicity, fetal effects and locomotor activity in rat offspring. Neurotoxicol Teratol 11: 65-69.
43. Hyman SE, Nestler EJ (1996): Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153: 151-162.
44. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN (2003): Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24: 566-573.
45. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Chiodo LM (1996): New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatrics 129: 581-589.
46. Jones SR, Lee TH, Wightman RM, Ellinwood EH (1996): Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) 126: 331-338.
47. Justice JB Jr (1993): Quantitative microdialysis of neurotransmitters. J Neurosci Methods 48: 263-276.
48. Kalivas PW, Duffy P (1993a): Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13: 266-275.
49. Kalivas PW, Duffy P (1993b): Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci 13: 276-284.
50. Kalivas PW, Stewart J (1991): Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16: 223-244.
51. Kandel DB, Wu P, Davies M (1994): Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Public Health 84: 1407-1413.
52. Keller RW Jr, Johnson KS, Snyder-Keller AM, Carlson JN, Glick SD (1996a): Effects of prenatal cocaine exposure on the mesocorticolimbic dopamine system: an in vivo microdialysis study in the rat. Brain Res 742: 71-79.
53. Keller RW Jr, LeFevre R, Raucci J, Carlson JN, Glick SD (1996b): Enhanced cocaine self-administration in adult rats prenatally exposed to cocaine. Neurosci Lett 205: 153-156.
54. Keller RW Jr, Maisonneuve IM, Nuccio DM, Carlson JN, Glick SD (1994): Effects of prenatal cocaine exposure on the nigrostriatal dopamine system: an in vivo microdialysis study in the rat. Brain Res 634: 266-274.
55. Koeltzow TE, Vezina P (2005): Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant selfadministration behavior in rats. Behav Brain Res 160: 250-259.
56. Kornetsky C, Bain G (1992): Brain-stimulation reward: a model for the study of the rewarding effects of abused drugs. NIDA Res Monogr 124: 73-93.
57. Kornetsky C, Duvauchelle C (1994): Dopamine, a common substrate for the rewarding effects of brain stimulation reward, cocaine, and morphine. NIDA Res Monogr 145: 19-39.
58. Kunko PM, Moyer D, Robinson SE (1993): Intravenous gestational cocaine in rats: effects on offspring development and weanling behavior. Neurotoxicol Teratol 15: 335-344.
59. Leech SL, Richardson GA, Goldschmidt L, Day NL (1999): Prenatal substance exposure: effects on attention and impulsivity of 6-yearolds. Neurotoxicol Teratol 21: 109-118.
60. Lester BM, LaGasse LL, Seifer R (1998): Cocaine exposure and children: the meaning of subtle effects. Science 282:633-634.
61. Lin D, Kellogg CK (1996): Neonatal exposure to cocaine enhances the reward-potentiating properties of the drug in young adult animals. Behav Neurosci 110: 791-801.
62. Malanga CJ, Kosofsky BE (2003): Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure. Brain Res Dev Brain Res 147: 47-57.
63. Malanga CJ, Pejchal M, Kosofsky BE (2007): Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice. Pharmacol Biochem Behav 87: 462-471.
64. Malanga CJ, Riday TT, Carlezon WA Jr, Kosofsky BE (2008): Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice. Biol Psychiatry 63: 214-221.
65. Malanga CJ, Riday TT, Kosofsky BE (2004): Comparison of locomotor-stimulating and rewarding effects of cocaine in mice. Abstr Soc Neurosci 29: 688-684.
66. Marinelli M, White FJ (2000): Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20: 8876-8885.
67. Martin-Fardon R, Sandillon F, Thibault J, Privat A, Vignon J (1997): Long-term monitoring of extracellular dopamine concentration in the rat striatum by a repeated microdialysis procedure. J Neurosci Methods 72: 123-135.
68. Mentis M, Lundgren K (1995): Effects of prenatal exposure to cocaine and associated risk factors on language development. J Speech Hear Res 38: 1303-1318.
69. Miller DB, Seidler FJ (1994): Prenatal cocaine eliminates the sex-dependent differences in activation observed in adult rats after cocaine challenge. Brain Res Bull 33: 179-182.
70. Miller MW, Waziri R, Baruah S, Gilliam DM (1995): Long-term consequences of prenatal cocaine exposure on biogenic amines in the brains of mice: the role of sex. Brain Res Dev Brain Res 87: 22-28.
71. National Institute on Drug Abuse (1995): NIDA Survey Provides First National Data on Drug Use during Pregnancy (Research Findings). Bethesda, NIDA.
72. Nestler EJ, Aghajanian GK (1997): Molecular and cellular basis of addiction. Science 278:58-63.
73. Norton CS, Galloway MP (1996): Repeated cocaine exposure attenuates the ability of 5-hydroxytryptamine to release striatal dopamine in vivo. Eur J Pharmacol 318: 323-326.
74. Nulman I, Rovet J, Altmann D, Bradley C, Einarson T, Koren G (1994): Neurodevelopment of adopted children exposed in utero to cocaine. CMAJ 151: 1592-1597.
75. O'Dell LE, Parsons LH (2004): Serotonin1b receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. J Pharmacol Exp Ther 311: 711-719.
76. Osborne PG, O'Connor WT, Drew KL, Ungerstedt U (1990): An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J Neurosci Methods 34: 99-105.
77. Osborne PG, O'Connor WT, Kehr J, Ungerstedt U (1991): In vivo characterisation of extracellular dopamine, GABA and acetylcholine from the dorsolateral striatum of awake freely moving rats by chronic microdialysis. J Neurosci Methods 37: 93-102.
78. Parsons LH, Justice JB Jr (1993a): Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606: 195-199.
79. Parsons LH, Justice JB Jr (1993b): Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J Neurochem 61: 1611-1619.
80. Paxinos GT, Franklin KB (1996): The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press.
81. Peris J, Coleman-Hardee M, Millard WJ (1992): Cocaine in utero enhances the behavioral response to cocaine in adult rats. Pharmacol Biochem Behav 42: 509-515.
82. Phillips PE, Johns JM, Lubin DA, Budygin EA, Gainetdinov RR, Lieberman JA, Wightman RM (2003): Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine. Brain Res 961: 63-72.
83. Pierce RC, Duffy P, Kalivas PW (1995): Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse 20: 33-36.
84. Pierce RC, Kalivas PW (1997): A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25: 192-216.
85. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA (2004): Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci 24: 3554-3562.
86. Ren JQ, Malanga CJ, Guerriero RM, Kosofsky BE (2004): Increased NAc dopamine release during cocaine sensitization in adult mice exposed to cocaine in utero: microdialysis studies. Abstr Soc Neurosci 29: 118.110.
87. Richardson GA, Conroy ML, Day NL (1997): Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol 18: 627-634.
88. Robinson TE, Berridge KC (1993): The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
89. Rocha BA, Mead AN, Kosofsky BE (2002): Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine. Psychopharmacology (Berl) 163: 221-229.
90. Salvatore MF, Hudspeth O, Arnold LE, Wilson PE, Stanford JA, Mactutus CF, Booze RM, Gerhardt GA (2004): Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum. Neuroscience 123: 481-490.
91. Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL, Kliegman R (2002): Cognitive and motor outcomes of cocaineexposed infants. JAMA 287: 1952-1960.
92. Sobrian SK, Burton LE, Robinson NL, Ashe WK, James H, Stokes DL, Turner LM (1990): Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol Biochem Behav 35: 617-629.
93. Sorg BA, Chen SY, Kalivas PW (1993): Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther 266: 424-430.
94. Spear LP (2000): The adolescent brain and agerelated behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
95. Tilakaratne N, Cai G, Friedman E (2001): Attenuation of cocaine-induced genomic and functional responses in prenatal cocaine-exposed rabbits. Pharmacol Biochem Behav 69: 225-232.
96. Tzschentke TM (1998): Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56: 613-672.
97. Unterwald EM, Ivkovic S, Cuntapay M, Stroppolo A, Guinea B, Ehrlich ME (2003): Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum. Brain Res Dev Brain Res 147: 67-75.
98. Vorhees CV, Reed TM, Acuff-Smith KD, Schilling MA, Cappon GD, Fisher JE, Pu C (1995): Long-term learning deficits and changes in unlearned behaviors following in utero exposure to multiple daily doses of cocaine during different exposure periods and maternal plasma cocaine concentrations. Neurotoxicol Teratol 17: 253-264.
99. Wang HY, Runyan S, Yadin E, Friedman E (1995a): Prenatal exposure to cocaine selectively reduces D 1 dopamine receptor-mediated activation of striatal Gs proteins. J Pharmacol Exp Ther 273: 492-498.
100. Wang HY, Yeung JM, Friedman E (1995b): Prenatal cocaine exposure selectively reduces mesocortical dopamine release. J Pharmacol Exp Ther 273: 1211-1215.
101. Wang XH, Levitt P, O'Brien Jenkins A, Murphy EH (1996): Normal development of tyrosine hydroxylase and serotonin immunoreactive fibers innervating anterior cingulate cortex and visual cortex in rabbits exposed prenatally to cocaine. Brain Res 715: 221-224.
102. Weiss F, Paulus MP, Lorang MT, Koob GF (1992): Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 12: 4372-4380.
103. Wilkins AS, Genova LM, Posten W, Kosofsky BE (1998a): Transplacental cocaine exposure. 1. A rodent model. Neurotoxicol Teratol 20: 215-226.
104. Wilkins AS, Jones K, Kosofsky BE (1998b): Transplacental cocaine exposure. 2. Effects of cocaine dose and gestational timing. Neurotoxicol Teratol 20: 227-238.
105. Wise RA (1996): Neurobiology of addiction. Curr Opin Neurobiol 6: 243-251.
106. Yablonsky-Alter E, Gashi E, Lidsky TI, Wang HY, Banerjee SP (2005): Clozapine protection against gestational cocaine-induced neurochemical abnormalities. J Pharmacol Exp Ther 312: 297-302.
107. Yan QS, Yan SE (2001): Activation of 5-Ht(1b/1d) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418: 55-64.
108. Zapata A, Chefer VI, Ator R, Shippenberg TS, Rocha BA (2003): Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice. Eur J Neurosci 17: 590-596.
109. Zetterstrom T, Sharp T, Collin AK, Ungerstedt U (1988): In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148: 327-334.
110. Zhang Y, Schlussman SD, Ho A, Kreek MJ (2003): Effect of chronic 'binge cocaine' on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57bl/6j and 129/J Mice. Synapse 50: 191-199.